Search Results

Deals

Castle Biosciences Completes Acquisition of AltheaDx

Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that it has completed its acquisition of AltheaDx, Inc. (AltheaDx).

April 26, 2022

·

7 min read

Deals

Castle Biosciences to Acquire AltheaDx

Castle Biosciences, Inc. today announced it has signed a definitive agreement to acquire AltheaDx, Inc.

April 4, 2022

·

10 min read

Biotech Beach

AltheaDx, Inc. launches webinar series on Mental Health; Precision Diagnostics for depression and anxiety

AltheaDx, a commercial stage precision medicine company with a leading pharmacogenomics test for depression and anxiety is launching a series of webinars.

June 7, 2021

·

3 min read

Biotech Beach

Live Webinar: AltheaDx hosts Dr. Kelly Wosnik to share practice patterns of PGx testing

On October 21th at 9AM PST / 12PM EST , Dr. Kelly Wosnik , Owner/ NP-C of Bristol Health will share practice patterns and associated clinical implications using pharmacogenomic testing (PGx) to pinpoint the right treatments for mental illnesses.

October 5, 2021

·

3 min read

Press Releases

Accellix Appoints Greg Hamilton as Chief Executive Officer as Company Accelerates Growth in Cell Therapy and Blood Bank Markets

September 24, 2024

·

2 min read

Biotech Beach

AltheaDx Closes $27 Million Series D Financing

April 25, 2017

·